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Striatal projection neuronsc neuronal differentiation and migration in the embryonic forebrain is a complex
mechanism that involves a variety of transcription factors such as the Dlx genes. At least four cis-acting
regulatory elements (CREs) are responsible for the Dlx transcriptional regulation in the subcortical
telencephalon and the rostral diencephalon. These include I12b and URE2 in the Dlx1/2 bigene cluster, and,
I56i and I56ii in the Dlx5/6 cluster. We previously reported that URE2, I12b, and I56i, mark different
progenitor cell populations in the ganglionic eminences as well as different subtypes of adult cortical
interneurons. Here, we carried out a detailed spatial and temporal analysis of the I56ii CRE activity in the
developing telencephalon between E10.5 and E15.5, and compared its activity with the other three Dlx CREs
using lacZ reporter genes in transgenic mice. We show that I56ii marks distinct group(s) of neurons located
in the superﬁcial mantle of the LGE and MGE between E11.5 and E13.5. The I56ii-positive cells are Dlx- and
GABA-immunoreactive. However, unlike the other CREs, I56ii does not label interneuron progenitors in the
basal ganglia, nor tangentially migrating cells to the cortex at E13.5. Instead, I56ii-positive cells mark a
subpopulation(s) of post-mitotic projection neurons that tangentially migrate from the LGE to the deep
mantle of the MGE and reside between the subventricular zone and the globus pallidus during midgestation.
The majority of these neurons express the striatal markers Meis2 and Islet1. Moreover, both Meis2 and Islet1
activate transcription of a reporter gene containing the I56ii sequence in co-transfection assays, indicating
that these transcriptional factors may be potential upstream modulators of the Dlx genes in vivo.
© 2008 Elsevier Inc. All rights reserved.IntroductionOver the past ﬁfteen years, genetic studies have focused on
elucidating the mechanisms underlying the development of the
telencephalon, one of the most complex and diverse regions in the
central nervous system (CNS). Several models of telencephalic
organization and development have emerged implicating a diverse
array of signaling molecules and transcription factors that control cell
fate speciﬁcation and proliferation as well as differentiation and
migration (for reviews; Guillemot, 2007; Puelles and Rubenstein,
2003; Schuurmans and Guillemot, 2002; Zaki et al., 2003). Hence,
programs of regional identity as deﬁned by the expression of distinct
transcription factors in different progenitor regions control most
aspects of histogenesis within the developing telencephalon. As a
result, the embryonic telencephalon is divided into the pallium
(primordium of neocortex, hippocampus, piriform cortex and amyg-
dala) and the subpallium (primordium of basal ganglia), which are, in
turn, subdivided into distinct progenitor domains (Marin et al., 2003b;l rights reserved.Puelles et al., 2000, 1999). Post-mitotic (immature) neurons are
generally derived from progenitor cells located nearby in the
ventricular zone (VZ) of the neuroepithelium before they translocate
to adjacent locations in the mantle through radial migration like
during the generation of cortical glutamatergic neurons (Rakic and
Lombroso, 1998). However, in some cases, cell types generated in
speciﬁc progenitor zone(s) migrate orthogonally to the radial axis of
the neural tube and intermingle with other neurons in a common ﬁnal
destination, where that cell type apparently is not made, at least in
large numbers. This process, known as tangential migration, is widely
spread in the developing CNS and contributes to the complexity of the
neuronal network found in the vertebrate brain (Corbin et al., 2001;
Marin and Rubenstein, 2001b). For instance, the majority of cortical
GABAergic interneurons (Anderson et al., 1997a, 2001; Cobos et al.,
2001; de Carlos et al., 1996; Gorski et al., 2002; He et al., 2001; Lavdas
et al., 1999; Nery et al., 2002; Tamamaki et al., 1997; Wichterle et al.,
2001) and cortical oligodendrocytes (Tekki-Kessaris et al., 2001;
Thomas et al., 2000) in mouse and chick are born to ventral
progenitors located in the subpallium and reach their ﬁnal destination
by tangential migration.
Several genes including Lhx6, Arx and the Dlx genes are involved in
the regulation of neuronal migration in the ventral telencephalon
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genes are transcription factors that are required for the proper
differentiation and migration of most ventrally-derived neurons
including striatal projection neurons and cortical interneurons. Thus,
Dlx1/Dlx2 null mice display a major block of cell differentiation in
the lateral and medial ganglionic eminences (LGE and MGE), and lack
both radial and tangential migration of several types of GABAergic,
dopaminergic and cholinergic interneurons derived from the sub-
pallium (Anderson et al., 1997a,b, 2001; Bulfone et al., 1998; Long et al.,
2007; Marin et al., 2000; Marin and Rubenstein, 2001b; Pleasure et al.,
2000; Yun et al., 2002). Four Dlx genes, Dlx1, Dlx2, Dlx5 and Dlx6, are
expressed in the forebrain and show highly overlapping expression
patterns but with subtle spatio-temporal differences in the telence-
phalon and diencephalon, suggesting the presence of both redundant
and unique functions among these genes (Panganiban and Ruben-
stein, 2002). Towards elucidating the biochemical mechanisms that
control development of ventral progenitors in the telencephalon, we
have investigated the regulatory elements and mechanisms control-
ling Dlx gene expression. We previously showed that shared
regulatory mechanisms may underlie the functional redundancy
among Dlx paralogs (Ghanem et al., 2003; Zerucha et al., 2000).
Hence, we identiﬁed and characterized four conserved regulatory
elements (CREs) acting as forebrain-speciﬁc enhancers for the Dlx
genes in vertebrates: I56i and I56ii in the Dlx5/Dlx6 bigene cluster
(Zerucha et al., 2000), and, URE2 and I12b in the Dlx1/Dlx2 cluster
(Ghanem et al., 2003, 2007). Furthermore, we reported that URE2,
I12b and I56i, mark different progenitor cell populations in the
ganglionic eminences and different subtypes of adult cortical inter-
neurons (Ghanem et al., 2007). These ﬁndings suggest that distinct Dlx
functions could be mediated by different regulatory elements and/or
mechanisms.
Here we expand our previous ﬁndings by demonstrating the
existence of a distinct regulatory role played by I56ii when compared
with the three Dlx CREs described earlier. We carried out a detailed
spatial and temporal analysis of the lacZ reporter transgene expression
driven by the I56ii CRE between E10.5 and E15.5 and compared its
activities with that of three previously described Dlx CREs. We report
that, unlike the other CREs, I56ii is not active in GABAergic
interneuron progenitors in the basal ganglia, nor in tangentially
migrating cells to the cortex. Instead, it targets lacZ expression
speciﬁcally to subpopulation(s) of post-mitotic projection neurons
that are probably derived from LGE progenitors and have tangentially
migrated to the deep mantle of the LGE and MGE between E11.5 and
E13.5. In addition, we also identify that the I56ii-positive neurons
express two striatal markers, Meis2 and Islet1, during midgestation,
both of which can activate transcription via I56ii in co-transfection
assays in vitro, suggesting these transcriptional factors may be
potential upstream regulators of Dlx genes in vivo. Together, our
data reﬂect a complex and dynamic regulation of Dlx gene expression
during the early stages of embryonic development through several
regulatory elements with overlapping and distinct function(s).
Materials and methods
Transgenic animals
For transgenic mice, sequences containing the four mouse
enhancers (URE2, I12b, I56i and I56ii) were subcloned separately
into the p1229/p1230 vectors (Yee and Rigby, 1993) that contain a
human β-globin minimal promoter and the lacZ reporter gene.
Subclonings were done using a PCR-based approach or using
convenient restriction sites and followed by sequencing to verify the
integrity of each insert. The p1230-based I12b-alkaline phosphatase
(I12b-AP) construct was generated as described earlier (Ghanem et al.,
2007). At least two independent transgenic lines that show lacZ or AP
staining were generated with each construct. Staining results onwhole mount embryos and on coronal sections of the forebrain were
replicated from independent lines. Transgenic animals were produced
and analyzed as previously described (Zerucha et al., 2000).
Histology
E10 to E12.5mouse embryos were ﬁxed for 45min to 2 h in 4% cold
paraformaldehyde (PFA) in 1× PBS at 4 °C, then, washed and stained
for β-galactosidase activity overnight (O/N) at 28 °C in a solution of
1 mg/ml X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, and
0.02% NP-40 in PBS. The stained brains were dissected and
equilibrated in 20% sucrose solution O/N at 4 °C prior to sectioning.
Brains were embedded in Tissue-Tek media the following day,
cryoprotected and processed for frozen sectioning at 20–50 μm
using a cryostat (Leica CM3050 S). Sections were mounted with
Aquatex (EM Science, VWR). E13.5-P0 mouse brains were ﬁxed for 2 h
to O/N in 4% cold PFA in PBS at 4 °C, dissected and sectioned prior to
staining. LacZ staining and mounting was performed as described
above.
Double immunohistochemistry
Frozen sections of E10.5–E15.5 mouse brain were dried for 1 h at
room temperature, then, washed for 3×5min each in 0.1 M phosphate
buffer (PB) to eliminate residues from tissue protection medium.
Immunostaining was performed as described earlier (Ghanem et al.,
2007). The following antibodies have been applied in this study:
guinea pig anti-β-gal (1:1000, a generous gift from Dr. Thomas
Sargent), rabbit pan-Dll antibody (anti-Dlx; 1:100, a kind gift fromDrs.
Grace Panganiban and J.L.R.R.), rabbit anti-human placental alkaline
phosphatase (PLAP, 1:100, Serotec), mouse anti-PCNA (1:300; Vector
Laboratories), mouse anti-MAP2 (1:300, Sigma), rabbit anti-active
caspase 3 (1:500, BD Biosciences), rabbit anti-GABA (1:4000, Sigma),
rabbit anti-calbindin (1:1000, Chemicon), rat anti-somatostatin
(1:100, Chemicon), rabbit anti-NPY (1:4000, Immunostar), rabbit
anti-TH (1:350, Chemicon), mouse anti-Islet1 (1:100, Developmental
Studies Hybridoma Bank), and goat anti-Meis2 (1:100, Santa Cruz
Biotechnology). Secondary antibodies were all purchased from
Invitrogen: goat anti-rabbit Alexa Fluor 488, goat anti-mouse Alexa
Fluor 488, goat anti-rat Alexa Fluor 488, donkey anti-goat Alexa Fluor
488, and goat anti-guinea pig Alexa Fluor 594. For PCNA detection,
sodium citrate antigen retrieval, pH 6.0, was performed on sections
before incubation with PCNA antibodies.
In situ RNA hybridization
In situ hybridization on frozen tissue sections and digoxigenin RNA
probe labeling were performed according to the procedures described
in (Wallace and Raff, 1999). Hybridized probes were detected with an
AP-conjugated anti-digoxigenin Fab fragment antibody (1:2000,
Roche) and visualized with the NBT/BCIP substrate system. Antisense
riboprobes for Dlx5 and Dlx6 were prepared as previously described
(Cobos et al., 2006; Long et al., 2007; Quint et al., 2000).
Co-transfection and chloramphenicol acetyltransferase (CAT) assays
The mouse I56ii CRE was ampliﬁed by PCR and inserted upstream
of the thymidine kinase (tk) minimal promoter in a pBLCAT2 vector,
we called it mI56ii-pBLCAT2. We also created, using the overlapping-
PCR method, a modiﬁed mI56ii-pBLCAT2 plasmid (mI56ii-mutant-
pBLCAT2) containing the mutagenized Meis2 consensus binding site
(TGTC to TCTA) in mI56ii sequence (position nt. 262 to nt. 265,
Supplementary Fig. S1). The mouse Islet1 cDNA encompassing the
full-length coding sequence (kindly provided by Dr. Steve M Sperber,
National Institute of Child Health and Human Development) was
subcloned into the EcoRI site of a pCS2+ expression vector, designated
Fig. 1. Comparative activities of URE2, I12b, I56i, and I56ii CREs in E10.5 transgenic mouse embryos (A–D) and coronal sections (E–H), as shown by the expression of lacZ reporter
gene. A, E: URE2-lacZ; B, F: I12b-lacZ; C, G: I56i-lacZ; D, H: I56ii-lacZ. Lateral views of the mouse embryos (A–D) show that all four CREs are able to target lacZ gene expression in two
main domains in the forebrain, the diencephalon (I) and most of the subpallial telencephalon (II). In URE2-lacZ, I12b-lacZ, and I56i-lacZ transgenic lines, lacZ positive cells are largely
absent from the VZ except for scattered cells in the URE2 and I56i lines (E, G; arrowheads), and are concentrated as a thick subpial layer (E–G). In contrast, I56ii-lacZ transgenics
produce only a few lacZ positive cells present in the subpial region of the LGE at this age (H, arrows). The red arrow in panel E indicates the boundary between the LGE and MGE. 3,
third branchial arch; H, hyoid arch (second arch); Hy, hypothalamus; L, limbs; LV, lateral ventricle; Md, mandible; OP, optic eminences; PT, prethalamus (ventral thalamus); ST,
subpallial telencephalon; St, somites. Scale bar: (A–D), 1 mm; (E–H), 12.5 μm.
Fig. 2.Different enhancer activities of URE2, I12b, I56i, and I56ii in the subpallial telencephalon of transgenic mice. Coronal hemisections showing lacZ expression under the control of
each enhancer at E11.5 (A–D) and E13.5 (E–H) in medial levels. A, E: URE2-lacZ; B, F: I12b-lacZ; C, G: I56i-lacZ; D, H: I56ii-lacZ. At both E11.5 and E13.5, URE2-lacZ, I12b-lacZ-, and I56i-
lacZ positive cells display a nearly homogeneous pattern of expression in most areas of the subpallium (A–C, E–G). In contrast, expression of the I56ii-lacZ transgene is mainly
restricted to a subset of cells in the superﬁcial mantle of the vLGE, MGE, AEP and POA (D, H, arrows), the regions where the other three CRE lines produce weak or no lacZ expression
(E–G, arrows).Unlike in the URE-lacZ, I12b-lacZ, and I56i-lacZ lines, I56ii-lacZ does not label cells migrating tangentially to the cortex at E13.5 (H versus E–G, arrowheads). DP, dorsal
telencephalon; LV, lateral ventricle; AEP, anterior entopeduncular area; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence, MZ, mantle zone, POA, pre-optic area;
SVZ, subventricular zone; VZ, ventricular zone. Scale bar: (A–H), 250 μm.
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generated in our laboratory (Zerucha et al., 2000). The pSV-β-Gal
reporter plasmid encoding β-galactosidase was purchased from
Promega and used as an internal control.
Co-transfection assays were performed as follows: brieﬂy, p19
murine embryonic carcinoma cells were seeded at a density of 3×105
in 60-mm-diameter tissue culture plates for 24–36 h prior to
transfection. Cells were subsequently transfected with 2 μg of
mI56ii-pBLCAT2, mI56ii-mutant-pBLCAT2, or enhancer-less pBLCAT2,
2 μg of each expression vector (Meis2-pCS2+, Islet1-pCS2+, or empty
pCS2+), and 2 μg of pSV-β-Gal using the lipofectamine 2000 reagent
(Invitrogen). The CAT activity in cell extracts was analyzed 48 h post-
transfection on TCL plates by applying the chloroform:methanol
solvent system and was quantiﬁed by a PhosphorImager as described
earlier (Zerucha et al., 2000). After normalizing to the β-galactosidase
activity, the relative CAT activity for each expression vector was
measured and compared to the basal level of activity seen in the
control. All experiments were repeated at least two times in triplicate.
Results
Spatio-temporal comparisons of lacZ expression in four Dlx CRE lines
during the development of the telencephalon
Divergence in the sequences of the four Dlx forebrain CREs namely,
URE2, I12b, I56i and I56ii, suggests that each of them is involved in
distinct aspects of Dlx regulation either spatially and/or temporally.
Previously, we showed that URE2, I12b and I56i, have some distinctFig. 3. The I56ii CRE is active in a number of Dlx5- and Dlx6-expressing cells in the telen
expression of the I56ii-lacZ transgene (E, F) in the telencephalon at E13.5. Note that a stripe
transcripts (C, E; arrowheads). Scale bar: (A, C, E), 200 μm; (B, D, F), 100 μm.and overlapping regulatory properties in the developing telencepha-
lon despite highly overlapping activities (Ghanem et al., 2007). To test
whether I56ii promotes expression with a distinct pattern, we
conducted a detailed spatial and temporal analysis of lacZ reporter
gene expression driven by this CRE in the telencephalon. We then
compared the lacZ reporter expression of I56ii-lacZ, and, I56i-lacZ,
URE2-lacZ and I12b-lacZ on coronal sections between E10.5 and E15.5.
All results were conﬁrmed in at least two independent transgenic
lines for each CRE.
E10–E10.5
The onset of lacZ expression conferred by all four CREs is detected
around E10 in a small cluster of cells located in the region of the
primordia of the prethalamus (previously known as the ventral
thalamus) (data not shown). This time point is comparable to the
onset of endogenous Dlx1 and Dlx2 expression in the prethalamus at
E9.0 and E9.5, respectively, as determined by in situ RNA hybridization
(Bulfone et al., 1993a; Price et al., 1991) and by RNA blot analysis
(McGuinness et al., 1996). This is also consistent with the onset of Dlx5
and Dlx6 expression which occurs around E9.5 (Simeone et al., 1994).
Shortly after their onset, lacZ expression in all four CRE lines
becomes visible in the two domains where endogenous Dlx genes are
expressed in whole mount embryos. Domain I (diencephalon)
includes expression in the prethalamus and a Dlx+ longitudinal
domain in the hypothalamus. Domain II encompasses most of the
subpallial telencephalon (Figs. 1A–D). In URE2-lacZ, I12b-lacZ, and
I56i-lacZ transgenics, β-galactosidase-positive cells are largely absentcephalon. Distribution of Dlx5 (A, B) and Dlx6 (C, D) transcripts was compared to the
of cells, where the I56ii CRE is particularly active, express relatively high levels of Dlx6
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scattered cells in the URE2 and I56i lines (Figs. 1E, G; arrowheads), and
are concentrated as a thick subpial layer (Figs. 1E–G). At this age, the
subpial tissue consists of the emerging subventricular zone (SVZ) and
mantle zone (MZ) (Yun et al., 2002). Unlike expression from the other
three CREs, I56ii-lacZ transgenics produce only a few lacZ positive
cells that are present in the subpial region of the LGE but not the MGE
at this age (Fig. 1H, arrows).
E11.5
Transgenic animals produced with all four reporter constructs
show stronger lacZ expression in the subpallial telencephalon at E11.5
compared to E10.5. Transgene expression in the forebrain is restricted
to regions where endogenous Dlx genes are expressed. ExpressionFig. 4. Characterization of the I56ii CRE activity in the LGE and MGE at E13.5. (A–D) Double
labeling using a pan-Dll antibody and a β-galactosidase speciﬁc antibody; (E–H) I56ii-lacZ po
I56i are active in distinct subpopulation(s) of cells at this time point; (I–L) at E13.5, most I56
PCNA, which marks all the proliferating cells; (M–P) I56ii-lacZ positive cells are post-mitotic
not apoptotic as they do not co-express the cell death marker, active-caspase 3. Cells expres
caspase 3 are shown in green, respectively. Panels D, H, L, P, T are high-magniﬁcation pictur
M–O, Q–S), 12.5 μm; (D, H, L, P, T), 8.7 μm.patterns of the four transgenes overlap extensively, even though
discrete and reproducible differences in enhancer activity are
observed, especially between the I56ii-lacZ transgene and the other
CREs (Figs. 2A–D and Supplementary Fig. S2). Therefore, URE2-lacZ,
I12b-lacZ, and I56i-lacZ are characterized by a nearly homogeneous
expression in the SVZ and MZ in most areas of the subpallium (Figs.
2A–C and Supplementary Figs. S2A–C, E–G) with the exception of the
VZ in I12b-lacZ and I56i-lacZ lines (Figs. 2B, C, and Supplementary Figs.
S2B, C, F, G), and, the ventral MGE (vMGE) in URE2-lacZ lines (Fig. 2A
and Supplementary Figs. S2A, E). In contrast, expression of the I56ii-
lacZ transgene is only detected in a subset of cells in the MZ that are
largely limited to parts of the ventral LGE (vLGE), dorsal and medial
MGE (dMGE and mMGE), pre-optic area (POA) and caudal ganglionic
eminence (CGE) (Fig. 2D and Supplementary Figs. S2D, H). Expression
of lacZ from all four transgenes is sparse in the septum at this ageimmunohistochemistry showing that I56ii-lacZ-expressing cells are Dlx-positive by co-
sitive cells do not overlap with I12b-AP-expressing cells, indicating that I56ii and I12b/
ii-lacZ positive cells have already exited the cell cycle because they do not express the
cells since they are co-localized with the molecular marker MAP2; (Q–T) these cells are
sing I56ii-lacZ are shown in red; while cells expressing Dlx, AP, PCNA, MAP2 or active-
es of boxes shown in panels C, G, K, O, S. GP, globus pallidus. Scale bars: (A–C, E–G, I–K,
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expression.
E12.5-E15.5
Regional differences in the activity of I56ii and the other three CREs
becomemore pronounced between E12.5 and E13.5, particularly in the
mantle of the ventral telencephalon. Consequently, I56ii-lacZ expres-
sion is still restricted to a subgroup of cells located in the deep mantle
of the LGE and septum at rostral level (Supplementary Figs. S3D and
S4D). It is also found along the superﬁcial mantle of the vLGE, MGE,
anterior entopeduncular area (AEP) and POA at medial level (Fig. 2H,
arrows, and Supplementary Fig. S3H), and in the deep MZ of the CGE
more caudally (Supplementary Figs. S3L and S4H, arrow). In contrast,
all of the above regions display weak or no lacZ expression in the other
CRE lines at E12.5 (Supplementary Figs. S3E–G, I–K) and E13.5 (Figs.
2E–G and Supplementary Figs. S4E–G, arrows), suggesting that I56ii
may be labeling a distinct group(s) of cells at these stages.
Furthermore, unlike in the URE2-lacZ, I12b-lacZ, and I56i-lacZ lines,
I56ii-lacZ does not label tangentially migrating cells to the cortex at
E13.5 (compare Fig. 2H, Supplementary Figs. S4D, H with Figs. 2E–G,
Supplementary Figs. S4A–C, E–G, respectively; arrowheads) and E15.5
(compare Supplementary Figs. S5D, H, and L with Supplementary Figs.
S5A–C, E–G, and I–K, respectively; arrowheads). Starting at E14.5, I56ii
activity is greatly reduced in the ventral telencephalon (data not
shown) and is only maintained in a group of hypothalamic cells
after E15.5 (Supplementary Figs. S5D, H, L). In contrast, theFig. 5. I56ii-lacZ positive cells are immunoreactive for GABA (A–D) at E13.5. In contrast to
interneuron progenitor cells (calbindin: E–H; somatostatin: I–L; NPY: M–P) in the basal ga
expressing cells that are calbindin-positive (H, arrowheads). Cells expressing I56ii-lacZ are sh
green, respectively. Panels D, H, L, P are high-magniﬁcation pictures of boxes shown in panexpression of URE2-lacZ and I56i-lacZ is still strong in the ganglionic
eminences at this time (Supplementary Figs. S5A, C, E, G, I, K and
data not shown). I12b-lacZ expression remains also visible in most
subdivisions of the basal ganglia but with weaker intensity
(Supplementary Figs. S5B, F, J).
In summary, our data suggest that I56ii CRE displays a different
activity compared with URE2, I12b and I56i, that is conﬁned to group
(s) of cells lining the mantle of the ganglionic eminences between
E11.5 and E13.5.
I56ii marks a subgroup of striatal projection neurons expressing Meis2
and Islet1
We sought to characterize the identity of the I56ii-lacZ positive cells.
First,we checked that I56ii-lacZ-expressing cells areDlx-positive between
E11.5 and E13.5 comparing sections stained with X-gal with consecutive
sections hybridized to Dlx5 or Dlx6 cRNA probes (Fig. 3 and data not
shown).We also applied double labelingwith a pan-Dll antibody and the
β-galactosidase antibody (Figs. 4A–D and data not shown). Interestingly,
we found that a stripe of cells that extends from the ventralMGE towards
the LGE and express the reporter transgene also express relatively high
levels of Dlx6 transcripts (Figs. 3C, E; arrowheads).
Then, in order to test whether I56ii and I12b/I56i are active in the
same or distinct group(s) of cells, we crossed the I56ii-lacZ linewith an
alkaline phosphatase (AP) reporter line under the control of I12b
(I12b-AP). We then performed double immunohistochemistry on
brain sections from double hemizygote embryos (AP+/lacZ+) at E12.5the other Dlx CREs (URE2, I12b, and I56i, Ghanem et al., 2007), I56ii is not active in
nglia or tangentially migrating cells to the cortex at E13.5, except for a few I56ii-lacZ-
own in red; whereas cells expressing GABA, calbindin, somatostatin or NPYare shown in
els C, G, K, O. Scale bars: (A–C, E–G, I–K, M–O), 12.5 μm; (D, H, L, P), 8.7 μm.
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I56ii-lacZ positive cells almost never overlap with cells expressing
the I12b-AP transgene at all levels and ages examined (Figs. 4E–H and
data not shown).
Next, we investigated whether I56ii-lacZ positive cells proliferate
and whether they undergo apoptosis after E13.5. We found that
between E11.5 and E13.5, most I56ii-lacZ positive cells have already
exited the cell cycle since they do not express the proliferating cell
nuclear antigen (PCNA), which marks all proliferating cells (Figs. 4I–L
and data not shown). In contrast, the vast majority of these cells
express microtubule associated protein-2 (MAP2), a marker of post-
mitotic neurons (Figs. 4M–P and data not shown). Furthermore, the
I56ii-lacZ-expressing cells do not appear to be in the process of
undergoing apoptosis at E13.5 as they did not co-express the cell
death marker, active-caspase 3 (Figs. 4Q–T).
Since Dlx genes are expressed in striatal projection neurons as well
as GABAergic interneurons both of which are derived form subpallial
progenitors,we testedwhether I56ii labels neurons belonging to either
of these two groups. First, we found that I56ii-lacZ-expressing cells
express GABA between E11.5 and E13.5 (Figs. 5A–D and data not
shown). However, they do not express any of the interneuron subtype-
speciﬁc molecular markers expressed at E13.5 including somatostatin
and neuropeptide Y (NPY) or the dopaminergic marker — tyrosine
hydroxylase (TH), suggesting that they are not immature interneurons
(Figs. 5E–P and data not shown). This is true except for a few I56ii-lacZ-
expressing cells that are calbindin-positive cells at E11.5 and E13.5 (Fig.Fig. 6. The I56ii CRE is active in a subset of cells expressing Islet1 andMeis2. The vast majority
the SVZ and more superﬁcial parts of the mantle of the ventral LGE (striatum) and the MGE
Meis2 (I–L) at E13.5. No such co-localization is observed for the I56i-lacZ positive cells at this
Islet1- or Meis2-positive cells are shown in green. Panels D, H, L, P: high magniﬁcations of box
H, L, P), 8.7 μm.5H, arrowheads and data not shown). As comparisons, the other three
CREs label one or more of these interneuron subtypes at E13.5
(Ghanem et al., 2007).
Some I56ii-lacZ positive cells express calbindin, a marker of both
striatal projection neurons and cortical interneurons; thus we investi-
gatedwhether I56ii-positive cells are striatal projection neurons.We co-
labeled these cells with two markers of striatal projection neurons,
Meis2 and Islet1, whose expression largely resembles that of I56ii-lacZ in
the MZ of the ganglionic eminences. The majority of I56ii-lacZ cells are
located in a deep mantle layer that is intercalated between the SVZ and
more superﬁcial parts of themantle of theventral LGE (striatum) and the
MGE (globus pallidus) (note: superﬁcial, as in the cortex, refers to being
close to pia). This region also expresses the Islet1 (Figs. 6A–D) andMeis2
(Figs. 6I–L) transcription factors at E13.5. In contrast, we did not detect
I56i-lacZ- nor I12b-lacZ-expressing cells that were co-labeled with
anti-Islet1 or anti-Meis2 antibodies at this age (Figs. 6E–H, M–P, and
Supplementary Figs. S6E–H, M–P). Only a fewweakly labeledURE2-lacZ
positive cells express either of the two transcription factors in themantle
of theMGE (Supplementary Figs. S6C, D, K, L). Note that, many cells that
strongly express URE2-lacZ also express Meis2 or Islet1, but these are
located in the mantle of the dorsal LGE where I56ii is not active
(Supplementary Figs. S6C, D, K, L).
Taken together, our results lead to the conclusion that I56ii-lacZ-
expressing cells in the subpallial telencephalon are a subpopulation(s)
of post-mitotic projection neurons that may be derived from ventral
LGE progenitor cells, as suggested by their expression of two striatalof I56ii-lacZ-expressing cells located in a deep mantle layer that is intercalated between
(globus pallidus) express two markers of striatal projection neurons, Islet1 (A–D) and
stage (Islet1: E–H;Meis2: M–P). Cell expressing I56ii-lacZ or I56i-lacZ are shown in red;
es shown in panels C, G, K, O, respectively. Scale bars: (A–C, E–G, I–K, M–O), 12.5 μm; (D,
Fig. 7. TheMeis2 and Islet1 proteins can activate reporter gene transcription via the I56ii
CRE in vitro. In a transient co-transfection assay, the activity of the CAT reporter
construct containing the I56ii sequence (mI56ii-pBLCAT2) was increased by the
transcription factors whereas almost no change was obtained when an enhancer-less
construct was co-transfected with Meis2. When one of the two potential Meis2 binding
sites in I56ii was mutagenized, a much lower fold activation was obtained in the
presence of Meis2. The values are presented as the mean±standard error on the mean
(SEM) and all experiments were repeated at least two times in triplicate.
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expressing cells compared to those where the other CREs, URE2, I12b,
and I56i, are active.
Meis2 and Islet1 proteins can bind and activate reporter gene
transcription via the I56ii enhancer sequence
To further clarify the existence of a potential regulation of the Dlx
genes by Meis2 and Islet1 proteins, we searched the I56ii sequence
using the genomatix software and identiﬁed two putative binding
sites (TGTC) for Meis homeodomain proteins as well as several
potential core binding sites (ATTA) for Islet proteins (Supplementary
Fig. S1). It is noteworthy that these ATTA-core motifs are also shared
by a large number of other homeodomain proteins, such as Hox and
Oct proteins (Gehring et al., 1994; Pankratova and Polanovsky, 1998).
To explore whether Meis2 or Islet1 binds and activates transcription
via these binding sites, we conducted transient co-transfection
reporter assays. As noted above, p19 embryonic carcinoma cells
were transfected with the mI56ii-pBLCAT reporter construct, together
with Meis2-pCS2+ or Islet1-pCS2+ expression vectors (see material
and methods for experimental details). We then quantiﬁed the
relative CAT activity in the presence of Meis2 or Islet1, and found
that it was signiﬁcantly increased by about 4.50- and 3.53-fold,
respectively, when compared to controls and after normalizationwith
the β-galactosidase expression (Fig. 7). Co-transfection of a modiﬁed
mI56ii-pBLCAT vector containing the mutant Meis2 binding site
(mI56ii-mutant-pBLCAT2) signiﬁcantly decreased the transcriptional
activation of the reporter gene in the same assay and virtually no
activation byMeis2was obtainedwith an enhancer-less vector (empty
pBLCAT2) (Fig. 7). These data suggest that both Meis2 and Islet1
proteins are potential upstream regulators of Dlx gene expression in
vivo and this regulation could be mediated by the I56ii CRE.
Discussion
In the present report, we analyzed the regulatory role of the I56ii
CRE in the mouse telencephalon using lacZ reporter transgenes. We
report that the I56ii CRE shows a strikingly different activity during
midgestation when compared with the other three Dlx CREs that are
also active in the forebrain: I56i from the Dlx5/6 bigene cluster and,
URE2 and I12b, from the Dlx1/2 cluster. Thus, the I56ii-lacZ-expressingcells display the following properties: 1) they express the transgene
more transiently, between E11.5 and E13.5. Their expression is
restricted to a deep mantle layer that is intercalated between the
subpallial SVZ and more superﬁcial parts of the mantle of the ventral
LGE (striatum) and the MGE (globus pallidus). The other three Dlx
CREs are weakly or not active in these cells (Fig. 2, arrows); 2) unlike
the other three Dlx CREs, the I56ii-lacZ-expressing cells do not express
markers of interneurons including somatostatin and NPY (Fig. 5 and
data not shown) and do not tangentially migrate to the cortex. Rather,
the I56ii-lacZ-expressing cells are a subpopulation of post-mitotic
GABAergic projection neurons expressing two striatal markers, Meis2
and Islet1 (Figs. 4–6); and, 3) both Meis2 and Islet1 proteins can
induce transcription in vitro via one or more putative binding sites
found in the I56ii sequence (Fig. 7).
Comparison of the lacZ reporter gene expression driven by the four Dlx
CREs with endogenous Dlx gene expression
The onset of expression of the lacZ transgene in all four CRE lines is
detected in a group of prethalamic cells around ~E10 and, therefore,
slightly contrasts with the onset of the endogenous Dlx gene
expression which occurs between E9 and E9.5. This difference could
be due to low levels of the β-galactosidase protein that are
undetectable before E10 and/or to the existence of other regulatory
sequence(s) that are necessary to reﬁne the temporal expression of the
Dlx genes. In all four transgenic lines, the β-galactosidase-positive cells
are Dlx-positive as suggested by their co-labeling with a pan-Dll
antibody (Figs. 4A–D and data not shown; Ghanem et al., 2007). In
addition, the patterns of enhancer activity between E10.5 and E15.5
overlap with the endogenous patterns of Dlx expression (Fig. 3 and
data not shown). However, the transgene expression in all lines
examined lacks one feature of telencephalic Dlx expression at E10.5:
previous studies showed that the dorsal LGE (dLGE) has a high
concentration of Dlx2+ cells in the VZ (Eisenstat et al., 1999; Yun et al.,
2002). As none of the transgenic lines studied here shows this
property, it suggests that this expression is conferred by an unknown
enhancer element. Furthermore, the β-galactosidase-positive neurons
are still found in the mouse neocortex at birth as well as one month
after birth in all CRE lines (Ghanemet al., 2007) except in the I56ii lines
where lacZ expression is maintained only in a group of hypothalamic
cells after E14.5 (Supplementary Figs. S5D, H, L and data not shown).
I56ii CRE displays a differential activity in comparison with the I56i, I12b
and URE2 CREs
Using double labeling, we showed that I56ii-lacZ- and I12b-AP-
expressing cells do not overlap between at E12.5 and E13.5 in the
ganglionic eminences (Figs. 4E–H and data not shown). We previously
showed that I12b and I56i are co-active in more than 80% of the
progenitor population(s) found in the proliferative zones between
E11.5 and E13.5 (Ghanem et al., 2007). Therefore, we can infer that
I56ii and I56i are likely to be active in distinct group(s) of cells at these
time points. Several lines of additional evidence support our
conclusion: 1) we found that I56ii-positive cells are Dlx+/GABA+.
They also speciﬁcally express Meis2 and Islet1, two markers of striatal
projection neurons that are primarily derived from the LGE. In
contrast, none of the other three lacZ-CRE transgenes co-expresses
Meis2 or Islet1 in the superﬁcial mantle of the ganglionic eminences,
except for a few cells weakly expressing URE2-lacZ (Fig. 6 and
Supplementary Fig. S6); 2) we showed that URE2, I12b, and I56i are
active in distinct subpopulations of immature cortical and hippocam-
pal interneurons that tangentially migrate from subpallium, including
populations expressing calbindin, somatostatin and NPY at E13.5
(Ghanem et al. 2007 and this study, data not shown). In addition, we
showed that expression from the three elements continue to mark
different subtypes of adult interneurons (Ghanem et al., 2007). In
423N. Ghanem et al. / Developmental Biology 322 (2008) 415–424contrast, the I56ii CRE is inactive in cells migrating tangentially to the
cortex and its activity is not detectable past E14.5 in the basal ganglia
as discussed earlier.
I56ii marks a subgroup of striatal projection neurons that are probably
derived from the ventral LGE that tangentially migrate into the pallium
Based on their proﬁle and pattern of expression as well as the
orientation of their migratory processes, we suggest that the I56ii-
lacZ-expressing cells are GABAergic projection neurons that may
derive from progenitors found in the ventral LGE and then migrate
tangentially following a dorsal-to-ventral route before they ﬁnally
settle down between the SVZ and the globus pallidus in the deep
mantle of the MGE (Figs. 2 and 6).
There is recent evidence of a novel dorsal-to-ventral tangential
migration of neural stem cells in the perinatal forebrain (Willaime-
Morawek et al., 2006). Furthermore, tangentially migrating cells can
translocate between subdivisions within the subpallium itself including
the LGE and MGE as well as the AEP and POA. For instance, progenitor
cells found in the AEP/POA region migrate dorsally into the striatum to
become cholinergic interneurons (Marin et al., 2000; Zhao et al., 2003).
Also, it was shown recently that a subgroup of projections neurons,
namely “corridor cells”, tangentially migrate from the LGE to the MGE
around E13.5 to establish a permissive route that is essential for
thalamocortical axon guidance in mouse (Lopez-Bendito et al., 2006).
Furthermore, the so-called “corridor cells” are GABAergic neurons that,
like the I56ii-lacZ-expressing cells described here, speciﬁcally express
LGEmarkers such as Islet1, Ebf1 andMeis2 (Lopez-Bendito et al., 2006). It
will be interesting to determine in the futurewhether I56ii is amarker of
these “corridor cells” during midgestation.
Meis2 and Islet1 are potential upstream regulators of Dlx genes
Our data suggest that the Dlx genes may be potentially regulated
by Meis2 and Islet1 to possibly maintain their activities via the I56ii
sequence, at least between E11.5 to E13.5. This observation is
supported by the ability of both proteins to activate the transcription
(by about 3.5–4.5 fold) of a reporter gene via I56ii in transient co-
transfection assays in vitro (Fig. 7). There are two potential binding
sites for Meis2 in I56ii (Supplementary Fig. S1) and when one of the
two sites is mutated in the above sequence, activation by Meis2 is
almost totally abolished. Future experiments such as chromatin
immunoprecipitation (ChIP) could determine whether this interac-
tion also take places in vivo. As for Islet1, it was not possible to
identify a precise binding site in I56ii as the binding preferences of
this transcriptional activator are poorly deﬁned as the ATTA sequence
which is found in several locations in I56ii (Supplementary Fig. S1)
and which is shared by numerous homeodomain transcription
factors.
In conclusion, we showed in the present study that I56ii-lacZ-
expressing cells in the ventral forebrain are a subpopulation(s) of
post-mitotic projection neurons that may be derived from progenitor
cells located in the LGE as suggested by their expression of two striatal
markers,Meis2 and Islet1. They constitute a distinct population of Dlx-
expressing cells compared to those where the other CREs, URE2, I12b
and I56i, are active. Therefore, the distinct activities of the four Dlx
CREs, we have identiﬁed thus far, reﬂect a complex and dynamic
spatio-temporal regulation of Dlx gene expression during the early
stages of embryonic development. Moreover, it highlights that the Dlx
genes may have distinct functions in distinct progenitor populations
born and derived from the basal ganglia.
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